Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

J. Fudala, Paul; Peter Bridge, T.; Herbert, Susan; O. Williford, William; Nora Chiang, C.; Jones, Karen; F. Collins, Joseph; W. Raisch, Dennis; Casadonte, Paul; Jeffrey Goldsmith, R.; Ling, Walter; Malkerneker, Usha; F. McNicholas, Laura; A. Renner, John; M. Stine, Susan; J. Tusel, Donald

doi:10.1056/nejmoa022164

Public

Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

Published in New England Journal of Medicine • Sep 3, 2003

Authors:

Paul J. Fudala

T. Peter Bridge

Susan Herbert

Abstract

BACKGROUND: Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone has been proposed, but its efficacy and safety have not been well studied. METHODS: We conducted a multicenter, randomized, placebo-controlled trial involving 326 opiate-addicted...

Subject

Buprenorphine

Medicine

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!